Celularity is a biotechnology company that develops and manufactures innovative cellular therapies for cancer and other diseases. The company was founded in 2017 by Robert Hariri and is headquartered in Florham Park, New Jersey. Celularity's proprietary technology platform enables the production of allogeneic, off-the-shelf cell therapies from placental cells, which have unique immunomodulatory and regenerative properties. The company has raised over $500 million in funding and has partnerships with several major pharmaceutical companies, including United Therapeutics and Sorrento Therapeutics.